A Chart Review of Rituximab Plus Repeated Cycles of Dexamethasone

"A Chart Review of Rituximab Plus Repeated Cycles of Dexamethasone for the Treatment of Relapsed/Refractory ITP:"

NCT02050581•Weill Medical College of Cornell University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Idiopathic Thrombocytopenia Purpura

Locations

United States

Locations (1)

New York Presbyterian Hospital Weill Cornell Medical College

New York, New York, United States

Key Dates

Start Date

January 1, 2011

Primary Completion Date

April 12, 2017

Last Updated

July 16, 2018

Sponsors

Lead Sponsor

Weill Medical College of Cornell University

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 16, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions